why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
First received: April 07, 2025

Clinical Trial: A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Blood

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: An Open-label, Fixed-sequence, Two-period Phase I Trial to Evaluate the Effect of Multiple Oral Doses of Erythromycin, a Moderate CYP3A4 Inhibitor, on the Pharmacokinetics of BI 1291583 at Steady Stat

Brief Summary: The main objective of this trial is to investigate the effect of erythromycin, a moderate CYP3A4 inhibitor on the pharmacokinetics of BI 1291583 at steady state.

Read more